185750 — Chong Kun Dang Pharmaceutical Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareBalancedMid CapContrarian

Market Cap
KR₩1tn
Enterprise Value
KR₩981bn
Revenue
KR₩2tn

Annual balance sheet for Chong Kun Dang Pharmaceutical, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	161,855	187,333	155,861	364,253	301,583
Net Total Accounts Receivable
Net Total Receivables	219,514	228,295	279,749	310,140	298,453
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	600,114	667,147	713,615	946,572	962,152
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	274,650	298,910	310,697	319,787	320,780
Net Intangible Assets
Long Term Investments
Other Long Term Assets
Total Assets	946,333	1,046,700	1,124,883	1,402,428	1,458,765
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	320,621	320,230	374,213	511,466	368,559
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Deferred Income Tax
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	394,906	480,690	502,490	586,734	564,796
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
Unrealized Gain / Loss
Other Equity
Total Equity	551,427	566,010	622,393	815,694	893,969
Total Liabilities & Shareholders' Equity	946,333	1,046,700	1,124,883	1,402,428	1,458,765
Total Common Shares Outstanding